Answer
Breastfeeding should be avoided during idarubicin hydrochloride treatment and for at least 14 days after the last dose because of the potential for serious adverse reactions in nursing infants.
Sources for this answer
- Zavedos 5mg CapsulesPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 16Document updated
Sources checked